Profile data is unavailable for this security.
About the company
Bluestar Adisseo Co is a China-based company principally engaged in the research, design, production and distribution of additives for animal nutrition. The Company’s products include functional products, special products and others. Its functional products include methionine, vitamins, ammonia sulfates, as well as sodium sulfates, among others. Its special products include enzyme preparations, organic selenium additives and others. The Company also provides carbon disulfide, sulfuric acid and preparation services. The Company operates its business in domestic and overseas markets.
- Revenue in CNY (TTM)13.53bn
- Net income in CNY327.58m
- Incorporated1999
- Employees2.73k
- LocationBluestar Adisseo CoNo. 9Beitucheng West Road, Chaoyang DistrictBEIJING 100029ChinaCHN
- Phone+86 1 061958799
- Fax+86 1 061958805
- Websitehttp://www.bluestar-adisseo.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China Resources Dubl-Crne Phrmctl Co Ltd | 10.32bn | 1.38bn | 22.63bn | 12.27k | 16.23 | 1.94 | -- | 2.19 | 1.34 | 1.34 | 10.07 | 11.24 | 0.6781 | 2.85 | 5.82 | 841,054.60 | 8.87 | 8.58 | 11.67 | 11.21 | 54.25 | 58.19 | 13.08 | 11.98 | 2.15 | -- | 0.0249 | 35.91 | 6.20 | 4.44 | 12.96 | 6.60 | 21.46 | -1.63 |
| Joincare Pharmaceutical Group Ind. Co. | 16.43bn | 1.42bn | 22.68bn | 14.37k | 15.83 | 1.59 | -- | 1.38 | 0.7676 | 0.7676 | 8.86 | 7.63 | 0.4522 | 2.36 | 5.57 | 1,143,551.00 | 7.98 | 8.46 | 16.51 | 18.84 | 61.23 | 62.72 | 17.64 | 17.00 | 2.11 | -- | 0.2247 | 28.86 | -2.90 | 8.24 | -3.99 | 15.58 | 11.53 | 2.38 |
| Tasly Pharmaceutical Group Co Ltd | 8.64bn | 1.10bn | 23.10bn | 9.22k | 21.06 | 1.82 | -- | 2.67 | 0.7342 | 0.7342 | 5.77 | 8.47 | 0.4899 | 1.72 | 10.80 | 937,046.80 | 5.93 | 5.47 | 7.21 | 7.25 | 65.67 | 48.42 | 12.11 | 8.94 | 2.73 | 5.91 | 0.2083 | 50.99 | 0.4236 | -13.57 | 505.34 | -7.07 | -3.03 | 1.92 |
| Xiamen Amoytop Biotech Co Ltd | 2.23bn | 600.08m | 24.62bn | 1.96k | 41.02 | 12.28 | -- | 11.06 | 1.48 | 1.48 | 5.47 | 4.93 | 1.04 | 0.8541 | 6.70 | 1,135,877.00 | 28.09 | 17.96 | 32.72 | 21.02 | 93.17 | 90.48 | 26.95 | 19.17 | 3.22 | -- | 0.0037 | 26.95 | 37.55 | 36.19 | 93.52 | 103.28 | 81.61 | -- |
| Zhejiang Huahai Pharmaceutical Co., Ltd. | 8.75bn | 928.37m | 24.83bn | 8.22k | 26.21 | 2.91 | -- | 2.84 | 0.6391 | 0.6391 | 6.02 | 5.76 | 0.4511 | 1.08 | 3.46 | 1,064,162.00 | 4.76 | 5.67 | 6.90 | 8.07 | 59.44 | 60.52 | 10.55 | 11.61 | 0.8451 | 5.48 | 0.5047 | 33.55 | 0.5199 | 10.28 | -28.88 | 50.51 | 7.21 | -- |
| Shanghai Junshi Biosciences Co Ltd | 1.63bn | -2.02bn | 25.61bn | 2.57k | -- | 4.32 | -- | 15.73 | -2.06 | -2.06 | 1.66 | 6.97 | 0.1348 | 1.05 | 4.11 | 634,034.10 | -18.18 | -18.87 | -23.17 | -23.11 | 64.05 | 69.13 | -134.86 | -88.41 | 1.91 | -215.80 | 0.3018 | -- | 3.38 | 248.39 | 4.38 | -- | 8.36 | -- |
| Bluestar Adisseo Co | 13.53bn | 327.58m | 26.77bn | 2.73k | 81.70 | 1.77 | -- | 1.98 | 0.1222 | 0.1222 | 5.04 | 5.63 | 0.6286 | 4.67 | 7.33 | 4,947,799.00 | 1.52 | 5.28 | 1.85 | 6.94 | 23.81 | 30.31 | 2.42 | 8.76 | 1.04 | 4.30 | 0.1325 | 21.81 | -9.26 | 2.92 | -95.82 | -43.75 | 2.74 | -19.09 |
| Kangmei Pharmaceutical Co Ltd | 4.93bn | 160.40m | 27.62bn | 4.41k | 171.11 | 3.89 | -- | 5.60 | 0.0116 | 0.0116 | 0.3572 | 0.5117 | 0.34 | 1.40 | 2.43 | 1,118,464.00 | 1.12 | -17.60 | 1.69 | -32.24 | 22.71 | -72.78 | 3.28 | -101.19 | 0.8746 | -- | 0.0465 | -- | 16.60 | -22.17 | 103.81 | -22.83 | -53.51 | -- |
| Shanghai Allist Pharmaceuticals Co Ltd | 1.62bn | 487.02m | 27.94bn | 870.00 | 57.36 | 7.66 | -- | 17.23 | 1.08 | 1.08 | 3.60 | 8.10 | 0.4513 | 1.96 | 9.77 | 1,863,318.00 | 13.56 | -6.70 | 14.46 | -7.38 | 94.94 | 96.63 | 30.04 | -49.48 | 8.50 | -- | 0.0006 | -- | 49.22 | 152.37 | 614.22 | -- | 152.72 | -- |
| Gan & Lee Pharmaceuticals | 2.61bn | 386.85m | 29.73bn | 4.48k | 74.40 | 2.72 | -- | 11.39 | 0.6726 | 0.6726 | 4.52 | 18.38 | 0.234 | 0.8926 | 10.97 | 582,412.30 | 3.47 | 8.30 | 3.71 | 8.83 | 72.29 | 85.39 | 14.83 | 26.44 | 7.74 | -- | 0.0006 | 13.65 | 52.31 | 1.78 | 177.37 | -18.30 | 1.50 | -- |
Data as of Mar 13 2024. Currency figures normalised to Bluestar Adisseo Co's reporting currency: Chinese Yuan Renminbi CNY
1.22%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Guotai Asset Management Co., Ltd.as of 30 Jun 2023 | 7.67m | 0.29% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2023 | 5.29m | 0.20% |
| HSBC Jintrust Fund Management Co. Ltd.as of 30 Jun 2023 | 4.21m | 0.16% |
| China Universal Asset Management Co., Ltd.as of 30 Jun 2023 | 3.01m | 0.11% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 3.01m | 0.11% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2023 | 2.90m | 0.11% |
| Manulife TEDA Fund Management Co., Ltd.as of 30 Jun 2023 | 1.96m | 0.07% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2023 | 1.71m | 0.06% |
| Essence Fund Co., Ltd.as of 30 Jun 2023 | 1.52m | 0.06% |
| China Merchants Fund Management Co., Ltd.as of 30 Jun 2023 | 1.35m | 0.05% |
More ▼
Data from 30 Jun 2023 - 31 Dec 2023Source: FactSet Research Systems Inc.
